Gainers
- Lucira Health LHDX shares rose 29.5% to $0.51 during Friday's after-market session. Lucira Health's trading volume hit 3.7 million shares by close, accounting for 93.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.7 million.
- NuCana NCNA stock moved upwards by 8.57% to $1.14. The market value of their outstanding shares is at $59.5 million.
- eFFECTOR Therapeutics EFTR stock moved upwards by 8.33% to $0.54. Trading volume for this security closed at 203.3K, accounting for 105.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.6 million.
- Revelation Biosciences REVB shares moved upwards by 8.29% to $0.22. The market value of their outstanding shares is at $5.2 million.
- Unicycive Therapeutics UNCY stock rose 6.77% to $0.47. The market value of their outstanding shares is at $7.0 million.
- Allarity Therapeutics ALLR shares moved upwards by 6.7% to $0.25. The company's market cap stands at $3.6 million.
Losers
- VYNE Therapeutics VYNE shares declined by 11.7% to $0.2 during Friday's after-market session. This security traded at a volume of 132.6K shares come close, making up 27.3% of its average volume over the last 100 days. The company's market cap stands at $11.5 million.
- Sharps Technology STSS shares fell 8.4% to $1.31. The company's market cap stands at $12.3 million.
- BiondVax Pharmaceuticals BVXV stock fell 6.34% to $2.81. At the close, BiondVax Pharmaceuticals's trading volume reached 2.7 million shares. This is 14228.0% of its average volume over the last 100 days. The company's market cap stands at $5.2 million.
- Achilles Therapeutics ACHL stock fell 5.09% to $1.12. At the close, Achilles Therapeutics's trading volume reached 79.5K shares. This is 28.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $45.8 million.
- Spectrum Pharmaceuticals SPPI shares fell 5.0% to $0.46. The market value of their outstanding shares is at $93.1 million.
- Spruce Biosciences SPRB shares decreased by 4.96% to $2.3. Spruce Biosciences's trading volume hit 16.4 million shares by close, accounting for 13652.6% of its average volume over the last 100 days. The company's market cap stands at $54.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in